{"id":10358,"date":"2022-11-18T09:55:53","date_gmt":"2022-11-18T09:55:53","guid":{"rendered":"https:\/\/qalabs.medicasapp.com\/in\/product\/ca-cyfra-21-1serum-3\/"},"modified":"2026-01-28T12:09:37","modified_gmt":"2026-01-28T12:09:37","slug":"ca-cyfra-21-1serum","status":"publish","type":"product","link":"https:\/\/qalabs.medicasapp.com\/in\/product\/ca-cyfra-21-1serum\/","title":{"rendered":"CA (Cyfra) 21-1,Serum"},"content":{"rendered":"

Blood, NA, Fasting or Non Fasting: As suggested by doctor<\/p>\n

\"sampleSample Required:\u00a0<\/span><\/h3>\n

The test requires a blood sample.<\/span><\/p>\n

\"testTest Time:\u00a0<\/span><\/h3>\n

Test results are typically available within a few hours to a day.<\/span><\/p>\n

\"testTest Normal Range:<\/span><\/h3>\n

The normal range for CA (Cyfra) 21-1 levels can vary depending on the laboratory’s reference values.<\/span><\/p>\n

\"whatWhat is the Test?\u00a0<\/span><\/h3>\n

The CA (Cyfra) 21-1 test measures the level of a protein called cytokeratin 19 fragment (Cyfra 21-1) in the blood. Elevated levels of Cyfra 21-1 can be associated with certain types of cancer, particularly lung cancer.<\/span><\/p>\n

\"testTest Procedure:<\/span><\/h3>\n

Blood Collection: A blood sample is drawn from a vein, usually from the arm. Laboratory Analysis: The blood sample is sent to a laboratory for analysis to measure the level of Cyfra 21-1.<\/span><\/p>\n

\"whenWhen to Take the Test:\u00a0<\/span><\/h3>\n

This test may be recommended for individuals who are suspected to have lung cancer or other cancers that can produce elevated levels of Cyfra 21-1.<\/span><\/p>\n

\"whoWho Should Take This Test:<\/span><\/h3>\n

Individuals with symptoms of lung cancer, such as persistent cough, chest pain, or difficulty breathing. Individuals with a history of lung cancer or other cancers associated with elevated Cyfra 21-1 levels<\/span><\/p>\n

\"precautionsPrecautions for Exceptional Cases (Pregnancy etc.):\u00a0<\/span><\/h3>\n

Pregnant individuals should inform their healthcare provider about their pregnancy status before taking the test, as pregnancy can affect test results.<\/span><\/p>\n","protected":false},"excerpt":{"rendered":"

Blood, NA, Fasting or Non Fasting: As suggested by doctor Sample Required:\u00a0 The test requires a blood sample. Test Time:\u00a0…<\/p>\n","protected":false},"featured_media":0,"template":"","meta":[],"product_brand":[],"product_cat":[63],"product_tag":[],"class_list":["post-10358","product","type-product","status-publish","product_cat-all-tests","first","instock","sale","shipping-taxable","purchasable","product-type-simple"],"acf":{"faqs":[{"faq_question":"Can elevated Cyfra 21-1 levels indicate cancers other than lung cancer?","faq_answer":"While Cyfra 21-1 is often associated with lung cancer, elevated levels can also be seen in other cancers that originate in the lining of certain organs, such as the bladder, esophagus, or cervix."},{"faq_question":"Is the CA (Cyfra) 21-1 test used for cancer screening?","faq_answer":"The CA (Cyfra) 21-1 test is not commonly used for general cancer screening. It is typically used in the diagnostic process for individuals with suspected lung cancer or specific types of cancers."},{"faq_question":"What factors can affect Cyfra 21-1 levels?","faq_answer":"Smoking and certain lung diseases can affect Cyfra 21-1 levels.It's crucial that you give your doctor your whole medical history."},{"faq_question":"Can Cyfra 21-1 levels be elevated in non-cancerous conditions?","faq_answer":"Yes, elevated levels can occur in non-cancerous lung conditions such as chronic obstructive pulmonary disease (COPD) or lung infections."},{"faq_question":"Can the CA (Cyfra) 21-1 test replace other cancer diagnostic tests?","faq_answer":"The CA (Cyfra) 21-1 test is often used in conjunction with other diagnostic tests, such as imaging scans and biopsies, to help confirm or rule out a cancer diagnosis. It is not used in isolation."}]},"yoast_head":"\n\n\n\n\n\n\n\n\n\n\n\n\n\t\n